Department of General Intensive Care and Institute for Nutrition Research, Rabin, Medical Center, Beilinson Campus, Petah Tikva 49100, Israel.
Laboratory of Nutrition and Metabolism Research, Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel-Aviv University, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel.
Nutrients. 2022 Apr 12;14(8):1589. doi: 10.3390/nu14081589.
Cycle ergometry (CE) is a method of exercise used in clinical practice. Limited data demonstrate its effectiveness in critically ill patients. We aimed to evaluate the combination of CE and a high-protein diet in critically ill patients.
This was an open label pilot trial comparing conventional physiotherapy with enteral nutrition (EN) (control, Group 1), CE with EN (Group 2), and CE with protein-enriched EN (Group 3). The primary outcome was length of ventilation (LOV). Secondary outcomes were intensive care unit (ICU) mortality, length of ICU stay (ICU LOS), length of hospital stay (Hospital LOS), and rate of re-intubation.
Per protocol, 41 ICU patients were enrolled. Thirteen patients were randomized to Group 1 (control), fourteen patients to Group 2, and fourteen patients to Group 3 (study groups). We found no statistically significant difference in LOV between the study arms (14.2 ± 9.6 days, 15.8 ± 7.1 days, and 14.9 ± 9.4 days, respectively, = 0.89). Secondary outcomes did not demonstrate any significant differences between arms.
In this pilot trial, CE combined with either standard EN or protein-enriched EN was not associated with better clinical outcomes, as compared to conventional physiotherapy with standard EN. Larger trials are needed in order to further evaluate this combination.
踏车运动(CE)是一种在临床实践中使用的运动方法。有限的数据表明其在危重症患者中的有效性。我们旨在评估 CE 与高蛋白饮食联合应用于危重症患者的效果。
这是一项开放标签的初步试验,比较了常规物理疗法与肠内营养(EN)(对照组,第 1 组)、CE 与 EN(第 2 组)和 CE 与高蛋白 EN(第 3 组)的组合。主要结局是通气时间(LOV)。次要结局是 ICU 死亡率、ICU 住院时间(ICU LOS)、住院时间(Hospital LOS)和再插管率。
根据方案,共纳入 41 例 ICU 患者。13 例患者随机分为第 1 组(对照组)、14 例患者分为第 2 组、14 例患者分为第 3 组(研究组)。我们发现研究组之间 LOV 无统计学差异(分别为 14.2 ± 9.6 天、15.8 ± 7.1 天和 14.9 ± 9.4 天, = 0.89)。次要结局在各组之间也未显示出任何显著差异。
在这项初步试验中,CE 联合标准 EN 或高蛋白 EN 与常规物理疗法联合标准 EN 相比,并未改善临床结局。需要更大规模的试验来进一步评估这种联合治疗。